Advertisement

90. Kongreß pp 1777-1792 | Cite as

Hämostaseologie

  • D. Engelhardt
  • W. Krell
  • G. Müller-Berghaus
  • W. Daiß
  • P. Ostendorf
  • K. Jaschonek
  • K. H. Zurborn
  • E. Bogat
  • H. D. Bruhn
  • H. Riess
  • G. Braun
  • G. Brehm
  • E. Hiller
  • T. Koschinsky
  • G. Bremer
  • A. Maier
  • F. A. Gries
  • H. Koderisch
  • J. Koderisch
  • H. Bechtold
  • K. Andrassy
  • E. Ritz
  • Ch. Karoff
  • W. Zidek
  • H. Losse
  • H. Vetter
Conference paper
Part of the Verhandlungen der Deutschen Gesellschaft für Innere Medizin book series (VDGINNERE, volume 90)

Zusammenfassung

Lösliches Fibrin wird im Plasma von Patienten mit Verbrauchskoagulopathie nachgewiesen und liegt hauptsächlich als des-AA-Fibrin vor. Dieser Fibrintyp entsteht durch Abspaltung der Fibrinopeptide A vom Fibrinogenmolekül. Es wird angenommen, daß des-AA-Fibrin durch Komplexbildung mit Fibrinogen in der Zirkulation in Lösung gehalten wird.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Mahn I, Müller-Berghaus G (1975) Studies on catabolism of ‘5I-labelled fibrinogen in normal rabbits and in rabbits with indwelling intravenous catheters: Methodologic aspects. Haemostasis 4: 40–50 —Google Scholar
  2. 2.
    Bernhard JC, Mahn I, Müller-Berghaus G (1981) Gelchromatographie von gereinigtem des-A-Fibrin in Humanplasma bei 20° C und 37° C. Verh Dtsch Ges Inn Med 87: 785–787Google Scholar
  3. 3.
    Shainoff JR, Page IH (1962) Significance of cryprofibrin in fibrinogen-fibrin conversion. J Exp Med 116: 697–707CrossRefGoogle Scholar
  4. 4.
    Mahn I, Krell W, Müller-Berghaus G (1979) Separation of human des-AB-Fibrin and Fibrinogen by Sepharose-plasma chromatography at 20° C and 37° C. Thromb Res 14: 651–663PubMedCrossRefGoogle Scholar
  5. 1.
    Vessey MP, Mann JI (1978) Female sex hormones and thrombosis. Br Med Bull 34: 157–162PubMedGoogle Scholar
  6. 2.
    Wessler S, Eitel SN, Wan LS, Pasternack BS (1976) Estrogen-containing oral contraceptive agents. A basis for their thrombogenecity. JAMA 19: 236Google Scholar
  7. 3.
    Yin TW, Wessler S, Butler JV (1973) Plasma heparin: A unique, practical, submicrogram-sensitive assay. Am J Lab Clin Med 2: 298Google Scholar
  8. 4.
    von Kaulla KN (1976) Östrogene und Blutgerinnung. Triangle 15: 1Google Scholar
  9. 5.
    Poller L (1978) Oral contraceptives, blood clotting and thrombosis. Br Med Bull 34: 151–156PubMedGoogle Scholar
  10. 6.
    Gitel SN, Wessler S (1975) Plasma antithrombin III: A quantitative assay of biological activity. Thromb Res 7: 5–16Google Scholar
  11. Gralnick HR (1973) Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukemia. Br J Haematol 24: 89PubMedCrossRefGoogle Scholar
  12. Myers TJ, Rickles FR, Barb Ch, Cronlund M (1981) Fibrinopeptide A in acute leukemia: Relationship of activation of blood coagulation to disease activity. Blood 57: 518Google Scholar
  13. Nossel HL, Younger LR, Wilner GD, Procupez T, Canfield RE, Butler Jr VP (1971) Radioimmunoassay of human fibrinopeptide A. Proc Natl Acad Sci USA 68: 2350PubMedCrossRefGoogle Scholar
  14. Nossel HL, Yudelman I, Canfield RE, Butler Jr VP, Spanondis K, Wilner GD, Qureshi GD (1974) Measurement of fibrinopeptide A in human blood. J Clin Invest 54: 43PubMedCrossRefGoogle Scholar
  15. Peuscher FW, Cleton FJ, Armstrong L, Stoepman van Dalen EA, van Mourik JA, van Aken WG (1980) Significance of plasma fibrinopeptide A (fpA) in patients with malignancy. J Lab Clin Med 96: 5PubMedGoogle Scholar
  16. Rickles FR, Edwards RL, Barb Ch, Cronlund M (1983) Abnormalities of blood coagulation in patients with cancer. Cancer 51: 301PubMedCrossRefGoogle Scholar
  17. Schramm W,Drost W, Schmidt M, Borlinghaus P, Marx R (1980) Fibrinopeptid A-Bestimmung, Methodik und klinische Ergebnisse. In: Schimpf K (Hrsg) Fibrinogen, Fibrin und Fibrinkleber. Schattauer, Stuttgart New York, p 391Google Scholar
  18. 1.
    Benveniste J, Cochrane CG, Henson PM (1972) Leukocytedependant histamine release from rabbit platelets: the role of IgE, basophile and a platelet-activating factor. J Exp Med 136: 1356–1377PubMedCrossRefGoogle Scholar
  19. 2.
    Blackwell GJ, Flower RJ, Russell-Smith N, Salmon JA, Thorogood PB, Vane JR (1978) Prostacyclin is produced in whole blood. Br J Pharmacol 64: 436Google Scholar
  20. 3.
    Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927–929PubMedCrossRefGoogle Scholar
  21. 4.
    Cardinal DC, Flower RJ (1980) The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 3: 135–158PubMedCrossRefGoogle Scholar
  22. 5.
    Gaarder A, Jonsen J, Laland S, Hellem AJ, Owren PA (1961) Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 192: 531–532PubMedCrossRefGoogle Scholar
  23. 1.
    Burrows AW, Chavin SI, Hockaday TDR (1978) Plasma-Thromboglobulin concentrations in diabetes mellitus. Lancet 1: 235–237PubMedCrossRefGoogle Scholar
  24. 2.
    Jones RL, Paradise C, Peterson CM (1981) Platelet survival in patients with diabetes mellitus. Diabetes 30: 486–489PubMedCrossRefGoogle Scholar
  25. 3.
    Bern MM (1978) Platelet functions in diabetes mellitus. Diabetes 27: 342–350PubMedCrossRefGoogle Scholar
  26. 4.
    Cella G, Zahavi J, de Haas HA, Kakkar VV (1979) ß-Thromboglobulin, platelet production time and platelet function in vascular disease. Br J Haematol 43: 127–136PubMedCrossRefGoogle Scholar
  27. 5.
    Janka HU, Standl E, Mehnert H (1981) Increased platelet adenylate cyclase activity in diabetic patients with microangiopathy. Metab Res (Suppl) 11: 26–29Google Scholar
  28. 6.
    Preston FE, Ward JD, Marcola BH, Porter NR, Timperley WR (1978) Elevated /3-Thromboglobulin levels and circulating platelet aggregates in diabetic microangiopathy. Lancet 1: 238–239PubMedCrossRefGoogle Scholar
  29. 7.
    Borsey Q, Fraser DM, Prose CW, Elton RA, Clarke BF (1980) Plasma Beta-Thromboglobulin in diabetes mellitus. Diabetologia 18: 353–357PubMedGoogle Scholar
  30. 8.
    Rasi V, Ikkala E, Hekali R, Myllylä G (1980) Factors affecting plasma ß-Thromboglobulin in diabetes mellitus. Med Biol 58: 269–272PubMedGoogle Scholar
  31. 9.
    Schernthaner G, Silberbauer K, Miihlhauser I, Willvonseder R (1979) Zur klinischen Bedeutung der radioimmunologischen Bestimmung von ß-Thromboglobulin and Plättchen-Faktor 4. Acta Med Austriaca 6: 375–379Google Scholar
  32. 1.
    Brown C et al. (1976) Defective platelet function following the administration of penicillin compounds. Blood 47: 949–956PubMedGoogle Scholar
  33. 2.
    Custer G et al. (1979) Effect of cefamandole naftate on blood coagulation and platelet function. Antimicrob Agents Chemother 16: 869–872PubMedCrossRefGoogle Scholar
  34. 3.
    Natelson E et al. (1976) Influence of cephalosporin antibiotics on blood coagulation and platelet function. Antimicrob Agents Chemother 9: 91–93PubMedCrossRefGoogle Scholar
  35. 4.
    Holt R et al. (1981) Hypoprothrombinemia in patients undergoing prolonged intensive care. Med J Aust 2: 716–719Google Scholar
  36. 5.
    Weitekamp M et al. (1983) Prolonged bleeding times and bleeding diathesis associated with moxalactam administration. JAMA 249: 69–71PubMedCrossRefGoogle Scholar
  37. 6.
    Bundesgesundheitsamt (1983) Sachstandsbericht zur Cephalosporinanhörung. Berlin, 19. August 1983Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • D. Engelhardt
    • 1
  • W. Krell
    • 1
  • G. Müller-Berghaus
    • 1
  • W. Daiß
    • 2
  • P. Ostendorf
    • 3
  • K. Jaschonek
    • 3
  • K. H. Zurborn
    • 4
  • E. Bogat
    • 4
  • H. D. Bruhn
    • 4
  • H. Riess
    • 5
  • G. Braun
    • 5
  • G. Brehm
    • 5
  • E. Hiller
    • 5
  • T. Koschinsky
    • 6
  • G. Bremer
    • 6
  • A. Maier
    • 6
  • F. A. Gries
    • 6
  • H. Koderisch
    • 7
  • J. Koderisch
    • 7
  • H. Bechtold
    • 7
  • K. Andrassy
    • 7
  • E. Ritz
    • 7
  • Ch. Karoff
    • 8
  • W. Zidek
    • 8
  • H. Losse
    • 8
  • H. Vetter
    • 8
  1. 1.Klin. Forschungsgruppe für Blutgerinnung und Thrombose der Max-Planck-Gesellschaft, Zentrum für Innere Medizin und Zentrale Abteilung des StrahlenzentrumsJustus-Liebig-UniversitätGießenDeutschland
  2. 2.Med. Univ.-Klinik, Abt. IderEberhard-Karls-UniversitätTübingenDeutschland
  3. 3.Med. Univ.-Klinik, Abt. IIEberhard-Karls-UniversitätTübingenDeutschland
  4. 4.I. Med. Univ.-KlinikKielDeutschland
  5. 5.III. Med. Klinik GroßhadernUniversität MünchenDeutschland
  6. 6.Diabetes-ForschungsinstitutUniversität DüsseldorfKlinische AbteilungDeutschland
  7. 7.Med. Univ.-KlinikenHeidelberg und MainzDeutschland
  8. 8.MünsterDeutschland

Personalised recommendations